文献速递功能神经外科

脑深部电刺激颅内出血的综合特征:1987年至2023年文献的系统综述

Comprehensive characterization of intracranial hemorrhage in deep brain stimulation: a systematic review of literature from 1987 to 2023.
PubMed 文献 · J Neurosurg · 2024-03-22

该系统综述纳入63项研究、13056例患者,评估脑深部电刺激(DBS)相关颅内出血(ICH)的患病率、部位、检测时机、临床影响及危险因素。ICH患病率为每例患者2.9%(固定效应模型,95%CI 2.62%-3.2%),每条DBS电极1.6%(随机效应模型,95%CI 1.34%-1.87%),其中49.6%有症状。术中微电极记录(MER)与ICH率升高相关(3.5±2.2 vs 2.1±1.4;p[T≤t]单尾=0.038)。

要点

  • DBS相关ICH患病率为每例患者2.9%、每条电极1.6%,49.6%有症状,发生率未随时间变化。
  • ICH最常发生于DBS电极周围:入口点16%、轨迹31%、靶点7%。
  • 术中MER与ICH率升高相关(3.5±2.2 vs 2.1±1.4;p[T≤t]单尾=0.038),其他危险因素包括术中收缩压>140 mm Hg、经脑沟轨迹及多次微电极插入。

核心结论

  • 本研究提供III级证据表明DBS术中MER是ICH的危险因素。
  • 其他危险因素包括术中收缩压>140 mm Hg、经脑沟轨迹及多次微电极插入。
  • 避免这些危险因素可能降低ICH发生率。

研究设计与样本

  • 系统综述,检索PubMed、EMBASE和Web of Science,检索词为脑出血和脑刺激两个概念,限定英文、人类研究、发表时间1980-2023年。
  • 纳入标准为DBS干预用于任何人类神经系统疾病,并记录出血并发症的部位和临床影响。
  • 排除非DBS干预、未记录出血结局、患者队列≤10例及儿科患者的研究。
  • 使用牛津循证医学中心证据等级评估偏倚风险,并对ICH患病率进行比例Meta分析。
  • 共纳入63项研究、13056例患者。

主要发现

  • ICH患病率为每例患者2.9%(固定效应模型,95%CI 2.62%-3.2%),每条DBS电极1.6%(随机效应模型,95%CI 1.34%-1.87%),其中49.6%有症状。
  • ICH发生率未随时间变化。
  • ICH最常发生于DBS电极周围:入口点16%、轨迹31%、靶点7%。
  • DBS术中MER与无MER相比ICH率升高(3.5±2.2 vs 2.1±1.4;p[T≤t]单尾=0.038)。
  • 60%的ICH在术后24小时检测到,27%在术中检测到;DBS全因死亡率为0.4%,ICH占死亡的22%。

关键数值与推荐

  • ICH患病率:每例患者2.9%(固定效应模型,95%CI 2.62%-3.2%),每条DBS电极1.6%(随机效应模型,95%CI 1.34%-1.87%)。
  • 症状性ICH占49.6%。
  • ICH部位:入口点16%、轨迹31%、靶点7%。
  • MER相关ICH率:MER组3.5±2.2 vs 无MER组2.1±1.4(p[T≤t]单尾=0.038)。
  • 其他危险因素:术中收缩压>140 mm Hg、经脑沟DBS轨迹、多次微电极插入。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Deep brain stimulation (DBS) is an effective treatment for medically refractory movement disorders and other neurological conditions. To comprehensively characterize the prevalence, locations, timing of detection, clinical effects, and risk factors of DBS-related intracranial hemorrhage (ICH), the authors performed a systematic review of the published literature. METHODS: PubMed, EMBASE, and Web of Science were searched using 2 concepts: cerebral hemorrhage and brain stimulation, with filters for English, human studies, and publication dates 1980-2023. The inclusion criteria were the use of DBS intervention for any human neurological condition, with documentation of hemorrhagic complications by location and clinical effect. Studies with non-DBS interventions, no documentation of hemorrhage outcome, patient cohorts of ≤ 10, and pediatric patients were excluded. The risk of bias was assessed using Centre for Evidence-Based Medicine Levels of Evidence. The authors performed proportional meta-analysis for ICH prevalence. RESULTS: A total of 63 studies, with 13,056 patients, met the inclusion criteria. The prevalence of ICH was 2.9% (fixed-effects model, 95% CI 2.62%-3.2%) per patient and 1.6% (random-effects model, 95% CI 1.34%-1.87%) per DBS lead, with 49.6% being symptomatic. The ICH rates did not change with time. ICH most commonly occurred around the DBS lead, with 16% at the entry point, 31% along the track, and 7% at the target. Microelectrode recording (MER) during DBS was associated with increased ICH rate compared to DBS without MER (3.5 ± 2.2 vs 2.1 ± 1.4; p[T ≤ t] 1-tail = 0.038). Other reported ICH risk factors include intraoperative systolic blood pressure > 140 mm Hg, sulcal DBS trajectories, and multiple microelectrode insertions. Sixty percent of ICH was detected at 24 hours postoperatively and 27% intraoperatively. The all-cause mortality rate of DBS was 0.4%, with ICH accounting for 22% of deaths. Single-surgeon DBS experience showed a weak inverse correlation (r = -0.27, p = 0.2189) between the rate of ICH per lead and the number of leads implanted per year. CONCLUSIONS: This study provides level III evidence that MER during DBS is a risk factor for ICH. Other risk factors include intraoperative systolic blood pressure > 140 mm Hg, sulcal trajectories, and multiple microelectrode insertions. Avoidance of these risk factors may decrease the rate of ICH.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Cheyuo C, Vetkas A, Sarica C, et al. Comprehensive characterization of intracranial hemorrhage in deep brain stimulation: a systematic review of literature from 1987 to 2023. J Neurosurg. 2024. PMID: 38518284. doi:10.3171/2024.1.JNS232385

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。